Xcout IntelXTL BIO
XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to sourcing and advancing medicinal products aimed at treating autoimmune conditions. Its principal experimental compound, hCDR1, is primed for Phase II clinical studies, addressing systemic lupus erythematosus and Sjogren's syndrome. The company operates under a licensing agreement with Yeda Research and Development Company Limited, granting it rights for the research, development, and commercialization of hCDR1 across numerous therapeutic applications. Originally incorporated in 1993 as Xenograft Technologies Ltd., the entity rebranded as XTL Biopharmaceuticals Ltd. in July 1995 and is currently headquartered in Ramat Gan, Israel.
Subscribe to see XTL BIO’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
XTL BIO at a glance
XTL BIO is a biotech company headquartered in Herzliya, Israel. It is publicly listed (XTLB) with a market capitalisation of $4.9M. Xcout tracks 9 named people at XTL BIO, including Noam Band (Chief Executive Officer & Director).
XTL BIO leadership
- Noam BandChief Executive Officer & Director
- Segal NivChief Financial Officer
- Ben-Zion WeinerDirector
- Fain Osnat HillelDirector
- Jennifer L GoodDirector
- Kenneth J ZuerblisDirector
3 more named people on record for XTL BIO, with roles, board committees and tenure — see the full roster →
Get XTL BIO's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on XTL BIO in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access